Search

everythinglearnresearchcommunity

for

Search:↓

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Prenatal antiandrogen treatment altered hormone levels in adult spotted hyenas, affecting males and females differently.

Some medicines can reduce excessive hair growth in women, but more research is needed to compare treatments and consider side effects.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Most patients improved with oral contraceptives, but some needed additional treatment.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

PCOS treatment focuses on inducing ovulation, reducing androgens, and managing long-term health risks with medications and lifestyle changes.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Low prolactin levels in PCOS can cause metabolic problems like insulin resistance and obesity.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

Male hormones and their interactions are crucial for male sexual development and characteristics.